Earnings Per Share (Tables)
|
9 Months Ended |
Sep. 30, 2025 |
|---|
| Earnings Per Share [Abstract] |
|
| Schedule of Earnings Per Share Computations |
Below is a summary of the earnings per share computations:
|
|
|
|
|
|
|
|
|
Three months ended September 30, |
|
2025 |
|
|
2024 |
|
Earnings per share – basic |
|
$ |
0.01 |
|
|
$ |
0.34 |
|
Earnings per share – diluted |
|
$ |
0.01 |
|
|
$ |
0.33 |
|
Weighted average shares of common stock outstanding – basic |
|
|
49,217,134 |
|
|
|
47,686,841 |
|
Weighted average shares of common stock outstanding – diluted |
|
|
49,473,417 |
|
|
|
48,223,788 |
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, |
|
2025 |
|
|
2024 |
|
Earnings per share – basic |
|
$ |
0.34 |
|
|
$ |
1.05 |
|
Earnings per share – diluted |
|
$ |
0.33 |
|
|
$ |
1.04 |
|
Weighted average shares of common stock outstanding – basic |
|
|
49,005,363 |
|
|
|
47,521,368 |
|
Weighted average shares of common stock outstanding – diluted |
|
|
49,311,384 |
|
|
|
47,960,686 |
|
|
| Schedule of Potentially Dilutive Outstanding Securities Excluded From Computation of Diluted Weighted Average Common Shares |
The following potentially dilutive outstanding securities were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being antidilutive or the conditions to issue such shares were not achieved as of September 30, 2025 and 2024, respectively:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30, |
|
|
For the Nine Months Ended September 30, |
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
Stock options |
|
|
113,490 |
|
|
|
155,990 |
|
|
|
117,562 |
|
|
|
155,990 |
|
Restricted stock awards and units |
|
|
474,786 |
|
|
|
— |
|
|
|
565,767 |
|
|
|
— |
|
Contingently issuable shares |
|
|
1,083,539 |
|
|
|
1,085,808 |
|
|
|
1,096,617 |
|
|
|
1,085,808 |
|
Total potentially dilutive securities |
|
|
1,671,815 |
|
|
|
1,241,798 |
|
|
|
1,779,946 |
|
|
|
1,241,798 |
|
|
| Schedule of Shares Included in the Diluted Earnings Per Share Computations |
Below is a summary of the shares included in the diluted earnings per share computations:
|
|
|
|
|
|
|
|
|
Three months ended September 30, |
|
2025 |
|
|
2024 |
|
Weighted average shares of common stock outstanding – basic |
|
|
49,217,134 |
|
|
|
47,686,841 |
|
Stock options |
|
|
72,442 |
|
|
|
169,785 |
|
Restricted stock awards and units and ESPP shares |
|
|
50,807 |
|
|
|
321,348 |
|
Contingently issuable shares |
|
|
133,034 |
|
|
|
45,814 |
|
Weighted average shares of common stock outstanding – diluted |
|
|
49,473,417 |
|
|
|
48,223,788 |
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, |
|
2025 |
|
|
2024 |
|
Weighted average shares of common stock outstanding – basic |
|
|
49,005,363 |
|
|
|
47,521,368 |
|
Stock options |
|
|
92,831 |
|
|
|
155,309 |
|
Restricted stock awards and units and ESPP shares |
|
|
74,038 |
|
|
|
243,806 |
|
Contingently issuable shares |
|
|
139,152 |
|
|
|
40,203 |
|
Weighted average shares of common stock outstanding – diluted |
|
|
49,311,384 |
|
|
|
47,960,686 |
|
|